医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Lianhua Qingwen Capsules Obtained Approval in the Philippines

2020年12月07日 PM12:00
このエントリーをはてなブックマークに追加


 

SHIJIAZHUANG CITY, China

Lianhua Qingwen Capsules, a Chinese traditional medicine produced by Yiling Pharmaceutical, has been approved by the Food and Drug Administration of the Philippines and become a Chinese medicine product officially recognized in the Philippines. Approved by the China National Medical Products Administration, Lianhua Qingwen Capsules is a Chinese traditional medicine that can treat lightly and ordinarily infected patients by novel coronavirus. The Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 1 to 8), jointly-published by the China National Health Commission and National Administration of Traditional Chinese Medicine, has suggested Lianhua Qingwen Capsules to be used during the medical observation period of novel coronavirus patients.

Up to now, Lianhua Qingwen Capsules has obtained approval certificates from nearly 20 countries, including the Philippines, and Yiling has been applying it for approval in more than 70 countries. The approval of Lianhua Qingwen in the Philippines is a win-win case: on one hand, there is an urgent need of medicine in the Philippines that can effectively treat the novel coronavirus, the market potential is huge, Lianhua Qingwen’s entry into the Philippine market is an important step of Yiling’s internationalization path; on the other hand, as a Chinese enterprise that would like to shoulder global responsibility, Yiling is willing to share its experience in the fight against the pandemic with the world, the ultimate beneficiary of Lianhua Qingwen’s approval in the Philippines will be the Philippine people.

China is holding great expectations to the performances of Lianhua Qingwen Capsules in the Philippines. The Chinese Embassy to the Philippines has issued a specific statement to congratulate the approval, and pointed out that the Philippine consumers better purchase and use the qualified products imported through legal channels, they are expecting Lianhua Qingwen to help the Philippine government and people fight the novel coronavirus pneumonia.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201206005002/en/

CONTACT

First Name: Li

Last Name: Kristy

E-mail:kristyli@chuhaimedia.com.cn

Phone No.: +86 85962566

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Seoul Viosys’ Violeds Modules Proven to Disinfect 99% of Airborne Viruses in a Recent Testing Result
  • Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan
  • Kaye推出适用于冷链运输市场的Kaye® Log -80℃ 疫苗温度记录器,以满足COVID-19疫苗储存和运输的要求
  • Kaye® (ケイ)は、COVID-19ワクチンの輸送・保管のニーズに応えるためにKaye® ログ -80ワクチン温度ロガーを、コールドチェーン市場向けに導入(発売)します。
  • DNP的新型非接触式透明屏幕可通过手的动作进行操作